Titan Medical Inc. (
NASDAQ:TMDIF -
Get Free Report) traded down 1.3% during trading on Friday . The stock traded as low as $0.46 and last traded at $0.46. 5,848 shares were traded during mid-day trading, a decline of 92% from the average session volume of 74,785 shares. The stock had previously closed at $0.47.
Titan Medical Trading Down 1.3%
The company's 50 day moving average is $0.38 and its 200-day moving average is $0.34. The stock has a market cap of $52.64 million, a PE ratio of -0.37 and a beta of 1.26.
About Titan Medical
(
Get Free Report)
Titan Medical Inc operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Titan Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Titan Medical wasn't on the list.
While Titan Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.